OpenAI Researcher Reportedly Raising $200M at $2B Valuation for AI Drug Startup
VraserX · x · 2026-07-31
An OpenAI researcher is reportedly in talks to raise $200 million at a $2 billion valuation for a new AI-driven drug discovery startup. The move highlights the immense capital power and premium valuation that talent from frontier AI labs currently commands in the market.
More from Companies & People
- How product leaders can harness AI early adopters without distracting the whole team — lennysan · 2026-10-17
- Anthropic bets voluntary scrutiny sets AI oversight terms before regulators act — VectorWireAI · 2026-10-17
- Google CEO Pichai calls Elon Musk's ability to 'will future technologies into existence' unparalleled — XFreeze · 2026-10-17
- Measuring AI adoption without telemetry: a 400-person firm's survey-plus-Claude approach — Expert-Birthday7928 · 2026-10-17
- One user made 24,000 Copilot requests in 24h: how firms audit 580 AI seats nobody tracks — alex_verem · 2026-10-17
- Ion Stoica at Stanford: humans specify and verify, models design and generate — RajaXg · 2026-10-17